The table records clinical developments using data from Informa Pharma Intelligence’s Biomedtracker. It lists drugs for which an important event was recorded between Dec. 30, 2016 and Jan. 5, 2017, divided by event type.
Events can include Phase II and Phase III trial initiations, development discontinuations, and the release of top-line and full clinical trial results